Expert Review of Neurotherapeutics

Article	Citations
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis	50
The latest developments with internet-based psychological treatments for depression	42
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review	38
Where Art Thou O treatment for diabetic neuropathy: the sequel	36
The relevance of cortical thickness in migraine sufferers and implications to therapy	36
Advances in the treatment and management of frontotemporal dementia	32
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study	32
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?	29
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men	29
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 2025	28
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms	27
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis	25
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease	24
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?	24
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives	24
Why is ADHD so difficult to diagnose in older adults?	22
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options	22
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents	21
Acute and long-term cognitive impairment following sepsis: mechanism and prevention	21
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies	21
Updated review on the link between cortical spreading depression and headache disorders	21
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead	21
Managing antipsychotic-related sexual dysfunction in patients with schizophrenia	20
Advances in the early diagnosis of amyotrophic lateral sclerosis	19
Correction	19

Treating subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: an update of the literature	19
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder	19
Hesitancies in primary headaches treatments	19
Mindfulness as a therapeutic option for obsessive-compulsive disorder	18
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms	18
Spinal automaticity of movement control and its role in recovering function after spinal injury	18
Emerging role for radiomics in the management of intracranial arteriovenous and cavernous malformations	17
Current and emerging diagnostic and management approaches for idiopathic intracranial hypertension	17
Current perspectives on the diagnosis, assessment, and management of vasculitic neuropathy	16
Clinical Insights and Strategies to Managing Depression Subtypes Associated with Tobacco dependence: A Response to the Letter to the Editor	16
Virtual reality technology in the treatment of anxiety – progress and future challenges	16
The differential diagnosis of autism spectrum disorder in adults	16
Diagnosing epileptic seizures in patients with Alzheimer’s disease and deciding on the appropriate treatment plan	16
Current use of neurotoxins for alleviating symptoms of cervical dystonia	16
Electroconvulsive therapy in patients with trauma and personality disorders: what is the evidence?	16
Multimodal approaches to the treatment of personality disorder	15
Considerations for hormonal therapy in migraine patients: a critical review of current practice	15
Advances in gene therapy for high-grade glioma: a review of the clinical evidence	15
The impact of sleep apnea on epilepsy treatment outcomes	14
Distinguishing essential tremor from Parkinson’s disease: clinical and experimental tools	14
Essential Tremor – Deep Brain Stimulation vs. Focused Ultrasound	14
Diagnostic advances and challenges in meningioma	14
Illuminating the way: the role of bright light therapy in the treatment of depression	14
Comparison of the retention rate, safety, and efficacy of two different titration protocols for lamotrigine in newly diagnosed epilepsy patients	13
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)	13
Cross-national reflections on medicinal cannabis and depression	13
Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review	13
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective	12
Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France	12
Psychotherapeutic treatments for generalized anxiety disorder: cognitive and behavioral therapies, enhancement strategies, and emerging efforts	12
Considering hearing loss as a modifiable risk factor for dementia	12
Frontotemporal dementia. How to deal with its diagnostic complexity?	12
Developing personalized treatment strategies for Parkinson’s disease based on disease subtypes	12
A novel treatment option for intrajejunal levodopa administration	12
Advancements in neuroactive peptides in seizures	12
Persistent post-concussion syndrome: pathophysiology, diagnosis, current and evolving treatment strategies	12
Long-term outcomes in refractory status epilepticus	12
Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease	11
Therapeutic issues in Guillain–Barré syndrome	11
Profiling aducanumab as a treatment option for Alzheimer’s disease: an overview of efficacy, safety and tolerability	11
A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients	11
Advances in the diagnosis of pediatric arterial ischemic stroke – imaging and beyond	11
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?	11
The effectiveness of electroconvulsive therapy (ECT) for people with bipolar disorder: is there a specific role?	11
Updated review of rescue treatments for seizure clusters and prolonged seizures	11
Current perspectives on the recognition and diagnosis of low CSF pressure headache syndromes	11
Using oral topiramate for primary generalized and focal-to-bilateral tonic-clonic seizures in patients 2 years of age and older: a review of the literature	11
Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review	11
Family accommodation: a diagnostic feature of obsessive-compulsive disorder?	10
Developments in targeting calcitonin gene-related peptide	10

Could self-reporting sleep duration become an important tool in the prediction of dementia?	10
Bipolar disorder staging and the impact it has on its management: an update	10
Imaging protocols for non-traumatic spinal cord injury: current state of the art and future directions	10
Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper	10
Teriflunomide: an oral therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis	10
Efficacy analysis of three brain stimulation techniques for Alzheimer’s disease: a meta-analysis of repeated transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain	9
Cognitive or daily stress association with headache and pain induction in migraine and tension-type headache patients: a systematic review	9
Imaging of infectious and inflammatory cystic lesions of the brain, a narrative review	9
Radiosurgical thalamotomy for essential tremor: state of the art, current challenges and future directions	9
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directions	9
An update on the role of magnetic resonance imaging in predicting and monitoring multiple sclerosis progression	9
Combinations of dextromethorphan for the treatment of mood disorders - a review of the evidence	9
Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease	9
Risk of suicide and suicide-related events in subjects treated with antiseizure medications	8
The benefits and risks of escalation versus early highly effective treatment in patients with multiple sclerosis	8
Ublituximab-xiiy as a treatment option for relapsing multiple sclerosis	8
Omaveloxolone for the treatment of Friedreich ataxia: clinical trial results and practical considerations	8
Contemporary perspectives in cerebral amyloid angiopathy	8
Rethinking the role of trazodone in the different depressive dimensions	8
Tobacco use disorder and depression: emerging strategies and recommendations:	8
Combination of noninvasive brain stimulation and constraint-induced movement therapy in patients with stroke: a systematic review and meta-analysis	8
What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis?	8
Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy	8
The pivotal role of central sensitization in long COVID, fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome	8
Long-term central nervous system (CNS) consequences of COVID-19 in children	8
What are the main challenges in the treatment of neonatal hypoxic ischemic encephalopathy?	8
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease	8
Deep brain stimulation: new programming algorithms and teleprogramming	8
Meniere disease subtyping: the direction of diagnosis and treatment in the future	8
Stem cell therapy for patients with paraplegia: is there hope for the future?	8
Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions	8
Learnings in developmental and epileptic encephalopathies: what do we know?	7
The challenges and opportunities related to the therapeutic use of music in psychiatry	7
Contemporary diagnosis and treatment of conduct disorder in youth	7
Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis	7
Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?	7
Suicide and suicidal behaviors: insight into clinical challenges and preventive measures	7
Insulin signaling in the central nervous system, a possible pathophysiological mechanism of anesthesia-induced delayed neurocognitive recovery/postoperative neurocognitive disorder: a narrative review	7
The complexities in the differential diagnosis of restless legs syndrome (Willis–Ekbom disease)	7
An update on pharmacotherapy for trigeminal neuralgia	7
Adaptive, personalized closed-loop therapy for Parkinson’s disease: biochemical, neurophysiological, and wearable sensing systems	7
The major challenges with pharmacologic management of chronic traumatic encephalopathy	7
Re-evaluating the prognosis of schizophrenia: tackling the issue of inadequate treatment	7
Current perspectives on the benefits, risks, and limitations of noninvasive brain stimulation (NIBS) for post-stroke dysphagia	7
A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children	7
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment	7
When is pharmacological intervention recommended for adults with social anxiety disorder?	6
Expert guidance on the differential diagnosis of neuroleptic malignant syndrome	6
Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis	6
Letter to the editor: reflections on the future of medical cannabis research for depression	6
A proposal for a shared therapeutic algorithm in children with prolonged convulsive seizures and status epilepticus	6
The burden of migraine in Mexico: a database analysis of migraine-related visits to emergency departments in Mexico’s Ministry of Health (MMoH) hospitals	6
What impact can brain stimulation interventions have on borderline personality disorder?	6
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomes	6
Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry	6
Updated perspectives on how and when lithium should be used in the treatment of mood disorders	6
Advances in stem cell-based therapeutic transfers for glioblastoma treatment	6
The changing landscape of neuroimaging in frontotemporal lobar degeneration: from group-level observations to single-subject data interpretation	6
Pharmacological approaches to the management of panic disorder in older patients: a systematic review	6
Obtaining long-term recovery: advances in optimizing treatment outcomes in patients with binge-eating disorder	6
Relationship between anti-seizure medication and behaviors that challenge in older persons with intellectual disability and epilepsy: a review	6
Is it possible to prevent relapse in panic disorder?	6
Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial	6
Neuromodulation as a therapeutic approach for post-traumatic stress disorder: the evidence to date	6
Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments	6
Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients	6
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders	6
The treatment of restless legs syndrome and periodic limb movement disorder: a plain language summary of the American Academy of Sleep Medicine Clinical Practice Guidelines	6
Current and emerging therapies for autoimmune encephalitis	6
Central vestibular dysfunction: don’t forget vestibular rehabilitation	6
Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression	5
Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant	5
Therapeutic plasma exchange for myasthenia gravis, Guillain-Barre syndrome, and other immune-mediated neurological diseases, over a 40-year experience	5
Current perspectives on the diagnosis and management of acute transverse myelitis	5
An overview of the efficacy and safety of brexpiprazole for the treatment of schizophrenia in adolescents	5
Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?	5
Sublingual dexmedetomidine: repurposing an anesthetic as an anti-agitation agent	5
Imaging of congenital and developmental cystic lesions of the brain: a narrative review	5
Pharmacological options for narcolepsy: are they the way forward?	5
Postoperative pain: a review of emerging therapeutic options	5

Correlation between systemic bleeding during thrombolysis and intracranial hemorrhage after thrombolysis in acute ischemic stroke	5
Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond	5
UK Medical Cannabis Registry: a cohort study of patients prescribed cannabis-based oils and dried flower for generalised anxiety disorder	5
Assessing cognitive impairment among pediatric epilepsies: a systematic review	5
The advances in the early and accurate diagnosis of Creutzfeldt–Jakob disease and other prion diseases: where are we today?	5
The promise and challenges of transcranial magnetic stimulation and deep brain stimulation as therapeutic options for obsessive-compulsive disorder	5
Challenges in the treatment of dysthymia: a narrative review	5
A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder	5
Pain in cervical dystonia: mechanisms, assessment and treatment	5
Therapeutic barriers for headache management: issues facing the global north and global south in 2024	5
How does “Pure-O” obsessive-compulsive disorder impact on a patient’s treatment plan?	5
What is the role of placebo in neurotherapeutics?	5
Rethinking the medication management of major depression	5
Why does exposure-based therapy fail in some individuals with obsessive-compulsive disorder?	5
Advances in the systemic therapy for recurrent meningiomas and the challenges ahead	5
Insights into headache 2022	5
Emerging antibody-based therapies for Huntington’s disease: current status and perspectives for future development	5
The utility of magnetoencephalography in epilepsy and its implications for treatment	4
Risk factors and disease associations in people living with idiopathic intracranial hypertension	4
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome	4
Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers	4
Can regular physical exercise be a treatment for panic disorder? A systematic review	4
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence	4
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry	4
Emerging frontiers in Chronic Traumatic Encephalopathy: early diagnosis and implications for neurotherapeutic interventions	4
Adapting psychedelic medicine for headache and chronic pain disorders	4
Real world considerations for newly approved CGRP receptor antagonists in migraine care	4
Accelerating the development of noninvasive brain stimulation devices: using design thinking to facilitate its clinical use and acceptance	4
Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses	4
How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?	4
Novel and emerging therapeutics for genetic epilepsies	4
Current and emerging treatment options for Angelman syndrome	4
Are ketamine and its enantiomers the answer to treatment-refractory depression?	4
An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke	4
New trends in the treatment of blepharospasm: replacing the standardized approach with a personalized approach	4
The impact of cognitive reserve relative to risk of Alzheimer’s disease and rate of progression: an up-to-date review of the literature	4
Brain atrophy assessment in multiple sclerosis: technical– and subject-related barriers for translation to real-world application in individual subjects	4
How could brain fingerprinting lead to the early detection of mental illness in adolescents and what are the next steps?	4
Viltolarsen: a treatment option for Duchenne muscular dystrophy patients who are amenable to exon 53 skipping therapy	3
Status epilepticus in pregnancy: a literature review and a protocol proposal	3
Pharmacological interventions to improve sleep in people with Alzheimer’s disease: a meta-analysis of randomized controlled trials	3
Advances in the treatment of familial dysautonomia: what does the future hold?	3
An evaluation of onobotulinumtoxinA as a therapeutic option for pediatric neurogenic detrusor overactivity	3
A systematic review of European regional and national guidelines: a focus on the recommended use of nabiximols in the management of spasticity in multiple sclerosis	3
Careful considerations for the treatment of posttraumatic stress disorder during and following pregnancy	3
Can pharmacotherapy help to reduce trichotillomania?	3
Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes	3
Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection	3
The importance of synthetic pharmacotherapy for recessive cerebellar ataxias	3
Emerging biomarkers to predict clinical outcomes in Guillain–Barré syndrome	3
Managing cognitive impairment in Parkinson’s disease: an update of the literature	3
The management of neurofibromatosis type 1 (NF1) in children and adolescents	3
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder	3
Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia	3
Essential tremor - drug treatments present and future	3
Withdrawal of antiseizure medications – for whom, when, and how?	3
Evaluating fenfluramine hydrochloride as an oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome	3
Novel techniques for early diagnosis and monitoring of Alzheimer’s disease	3
Zonisamide oral suspension as adjunctive therapy for treating partial seizures in adults and in pediatric patients aged 16 years and older with epilepsy	3
Impact of psychiatric comorbidities on the treatment of epilepsies in adults	3
Nanomaterials in neuromodulation: what is the potential?	3
Current perspectives on the clinical management of cryptogenic stroke	3
Overcoming clinical challenges of refractory neuropathic pain	3
The human functional connectome in neurodegenerative diseases: relationship to pathology and clinical progression	3
Guidance on antipsychotic selection for agitation and aggressive behavior in persons with Huntington’s disease	3
Overcoming barriers to the management of seizure clusters: ease of use and time to administration of rescue medications	3
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis	3